Fonar Corporation
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company of… Read more
Fonar Corporation (FONR) - Net Assets
Latest net assets as of December 2025: $162.86 Million USD
Based on the latest financial reports, Fonar Corporation (FONR) has net assets worth $162.86 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($217.22 Million) and total liabilities ($54.36 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $162.86 Million |
| % of Total Assets | 74.97% |
| Annual Growth Rate | N/A |
| 5-Year Change | 18.27% |
| 10-Year Change | 163.43% |
| Growth Volatility | 1434.35 |
Fonar Corporation - Net Assets Trend (1985–2025)
This chart illustrates how Fonar Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Fonar Corporation (1985–2025)
The table below shows the annual net assets of Fonar Corporation from 1985 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $160.10 Million | +2.12% |
| 2024-06-30 | $156.79 Million | +3.95% |
| 2023-06-30 | $150.83 Million | +3.14% |
| 2022-06-30 | $146.24 Million | +8.03% |
| 2021-06-30 | $135.37 Million | +7.23% |
| 2020-06-30 | $126.24 Million | +6.88% |
| 2019-06-30 | $118.11 Million | +15.53% |
| 2018-06-30 | $102.23 Million | +23.31% |
| 2017-06-30 | $82.91 Million | +36.42% |
| 2016-06-30 | $60.78 Million | +19.68% |
| 2015-06-30 | $50.78 Million | +10.62% |
| 2014-06-30 | $45.91 Million | +21.45% |
| 2013-06-30 | $37.80 Million | +241.10% |
| 2012-06-30 | $11.08 Million | +88.92% |
| 2011-06-30 | $5.87 Million | +201.56% |
| 2010-06-30 | $-5.78 Million | -100.76% |
| 2009-06-30 | $-2.88 Million | +29.45% |
| 2008-06-30 | $-4.08 Million | -143.25% |
| 2007-06-30 | $9.43 Million | -69.69% |
| 2006-06-30 | $31.12 Million | -40.61% |
| 2005-06-30 | $52.39 Million | +20.34% |
| 2004-06-30 | $43.54 Million | +33.04% |
| 2003-06-30 | $32.72 Million | -9.02% |
| 2002-06-30 | $35.97 Million | -14.33% |
| 2001-06-30 | $41.98 Million | -18.17% |
| 2000-06-30 | $51.31 Million | -13.48% |
| 1999-06-30 | $59.30 Million | -18.43% |
| 1998-06-30 | $72.70 Million | -0.95% |
| 1997-06-30 | $73.40 Million | +52.28% |
| 1996-06-30 | $48.20 Million | +21.41% |
| 1995-06-30 | $39.70 Million | +37.37% |
| 1994-06-30 | $28.90 Million | +60.56% |
| 1993-06-30 | $18.00 Million | +39.53% |
| 1992-06-30 | $12.90 Million | +30.30% |
| 1991-06-30 | $9.90 Million | +67.80% |
| 1990-06-30 | $5.90 Million | +1080.00% |
| 1989-06-30 | $500.00K | -95.90% |
| 1988-06-30 | $12.20 Million | +38.64% |
| 1987-06-30 | $8.80 Million | +8700.00% |
| 1986-06-30 | $100.00K | +102.27% |
| 1985-06-30 | $-4.40 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Fonar Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1961067600.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $660.00 | 0.00% |
| Other Components | $177.90 Million | 103.06% |
| Total Equity | $172.61 Million | 100.00% |
Fonar Corporation Competitors by Market Cap
The table below lists competitors of Fonar Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Paiho Shih Holdings Corp
TW:8404
|
$92.78 Million |
|
Fiera Milano S.p.A.
LSE:0EGH
|
$92.87 Million |
|
Singatron Enterprise Co Ltd
TWO:6126
|
$92.90 Million |
|
Boiron SA
PA:BOI
|
$92.91 Million |
|
Aroa Biosurgery Ltd
AU:ARX
|
$92.74 Million |
|
Lagenda Properties Bhd
KLSE:7179
|
$92.73 Million |
|
CAMBI ASA NK -02
F:3W7
|
$92.70 Million |
|
Korea Alcohol Industrial Co. Ltd
KQ:017890
|
$92.69 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Fonar Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 165,967,997 to 172,608,186, a change of 6,640,189 (4.0%).
- Net income of 8,334,261 contributed positively to equity growth.
- Share repurchases of 1,806,646 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $8.33 Million | +4.83% |
| Share Repurchases | $1.81 Million | -1.05% |
| Other Changes | $112.57K | +0.07% |
| Total Change | $- | 4.00% |
Book Value vs Market Value Analysis
This analysis compares Fonar Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.70x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-06-30 | $-5.38 | $18.45 | x |
| 1986-06-30 | $0.13 | $18.45 | x |
| 1987-06-30 | $11.00 | $18.45 | x |
| 1988-06-30 | $13.56 | $18.45 | x |
| 1989-06-30 | $0.56 | $18.45 | x |
| 1990-06-30 | $6.62 | $18.45 | x |
| 1991-06-30 | $11.31 | $18.45 | x |
| 1992-06-30 | $16.00 | $18.45 | x |
| 1993-06-30 | $15.20 | $18.45 | x |
| 1994-06-30 | $23.58 | $18.45 | x |
| 1995-06-30 | $21.86 | $18.45 | x |
| 1996-06-30 | $23.21 | $18.45 | x |
| 1997-06-30 | $32.62 | $18.45 | x |
| 1998-06-30 | $29.49 | $18.45 | x |
| 1999-06-30 | $23.14 | $18.45 | x |
| 2000-06-30 | $19.43 | $18.45 | x |
| 2001-06-30 | $17.91 | $18.45 | x |
| 2002-06-30 | $14.05 | $18.45 | x |
| 2003-06-30 | $10.68 | $18.45 | x |
| 2004-06-30 | $11.36 | $18.45 | x |
| 2005-06-30 | $12.95 | $18.45 | x |
| 2006-06-30 | $6.89 | $18.45 | x |
| 2007-06-30 | $1.85 | $18.45 | x |
| 2008-06-30 | $-0.87 | $18.45 | x |
| 2009-06-30 | $-0.58 | $18.45 | x |
| 2010-06-30 | $-1.17 | $18.45 | x |
| 2011-06-30 | $-0.27 | $18.45 | x |
| 2012-06-30 | $0.83 | $18.45 | x |
| 2013-06-30 | $2.28 | $18.45 | x |
| 2014-06-30 | $4.04 | $18.45 | x |
| 2015-06-30 | $6.09 | $18.45 | x |
| 2016-06-30 | $7.98 | $18.45 | x |
| 2017-06-30 | $11.61 | $18.45 | x |
| 2018-06-30 | $15.38 | $18.45 | x |
| 2019-06-30 | $17.60 | $18.45 | x |
| 2020-06-30 | $18.90 | $18.45 | x |
| 2021-06-30 | $20.54 | $18.45 | x |
| 2022-06-30 | $22.49 | $18.45 | x |
| 2023-06-30 | $23.31 | $18.45 | x |
| 2024-06-30 | $25.62 | $18.45 | x |
| 2025-06-30 | $26.35 | $18.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Fonar Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.83%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.99%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 1.26x
- Recent ROE (4.83%) is above the historical average (-25.13%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 0.00% | -115.29% | 0.62x | 0.00x | $-9.37 Million |
| 1986 | 1400.00% | 3.81% | 1.68x | 218.00x | $1.39 Million |
| 1987 | 12.50% | 2.63% | 1.20x | 3.97x | $220.00K |
| 1988 | 13.11% | 2.72% | 1.34x | 3.60x | $380.00K |
| 1989 | -2420.00% | -26.36% | 0.99x | 92.40x | $-12.15 Million |
| 1990 | 83.05% | 14.71% | 0.80x | 7.05x | $4.31 Million |
| 1991 | 35.35% | 17.07% | 0.51x | 4.07x | $2.51 Million |
| 1992 | 4.69% | 3.05% | 0.49x | 3.16x | $-680.00K |
| 1993 | 1.11% | 1.19% | 0.39x | 2.38x | $-1.60 Million |
| 1994 | -1.06% | -1.95% | 0.32x | 1.71x | $-3.13 Million |
| 1995 | -4.57% | -12.77% | 0.26x | 1.39x | $-5.74 Million |
| 1996 | -7.07% | -25.95% | 0.21x | 1.31x | $-8.21 Million |
| 1997 | 76.64% | 318.75% | 0.16x | 1.46x | $48.78 Million |
| 1998 | -7.85% | -20.65% | 0.25x | 1.49x | $-12.96 Million |
| 1999 | -23.95% | -38.48% | 0.38x | 1.65x | $-20.13 Million |
| 2000 | -21.36% | -28.04% | 0.46x | 1.65x | $-16.08 Million |
| 2001 | -36.30% | -32.68% | 0.55x | 2.04x | $-19.37 Million |
| 2002 | -64.10% | -51.22% | 0.61x | 2.04x | $-26.45 Million |
| 2003 | -46.35% | -28.37% | 0.90x | 1.81x | $-18.24 Million |
| 2004 | -22.00% | -13.26% | 0.93x | 1.79x | $-13.81 Million |
| 2005 | 1.96% | 0.97% | 1.38x | 1.47x | $-4.17 Million |
| 2006 | -98.50% | -90.59% | 0.58x | 1.88x | $-33.01 Million |
| 2007 | -287.02% | -76.90% | 0.81x | 4.63x | $-26.43 Million |
| 2008 | 0.00% | -37.98% | 1.01x | 0.00x | $-13.08 Million |
| 2009 | 0.00% | 2.82% | 1.40x | 0.00x | $1.42 Million |
| 2010 | 0.00% | -9.47% | 1.47x | 0.00x | $-2.44 Million |
| 2011 | 0.00% | 9.54% | 1.05x | 0.00x | $3.30 Million |
| 2012 | 115.88% | 14.64% | 1.17x | 6.74x | $5.28 Million |
| 2013 | 61.49% | 17.66% | 0.67x | 5.18x | $7.27 Million |
| 2014 | 41.07% | 15.18% | 0.89x | 3.03x | $7.86 Million |
| 2015 | 33.63% | 18.70% | 0.90x | 1.99x | $9.07 Million |
| 2016 | 30.02% | 21.43% | 0.86x | 1.62x | $10.49 Million |
| 2017 | 25.34% | 25.14% | 0.79x | 1.28x | $11.88 Million |
| 2018 | 21.52% | 26.04% | 0.69x | 1.20x | $11.36 Million |
| 2019 | 13.21% | 17.57% | 0.65x | 1.15x | $3.72 Million |
| 2020 | 6.53% | 9.62% | 0.48x | 1.43x | $-4.38 Million |
| 2021 | 7.37% | 11.35% | 0.47x | 1.37x | $-3.63 Million |
| 2022 | 8.28% | 12.75% | 0.49x | 1.33x | $-2.59 Million |
| 2023 | 5.94% | 9.50% | 0.49x | 1.27x | $-6.41 Million |
| 2024 | 6.37% | 10.27% | 0.48x | 1.29x | $-6.03 Million |
| 2025 | 4.83% | 7.99% | 0.48x | 1.26x | $-8.93 Million |
Industry Comparison
This section compares Fonar Corporation's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Fonar Corporation (FONR) | $162.86 Million | 0.00% | 0.33x | $92.74 Million |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |